The DOI matches its Crossref record.
Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure
Open accessAbstract
Hurler's syndrome (HS), the most severe form of mucopolysaccharidosis type-I, causes progressive deterioration of the central nervous system and death in childhood. Allogeneic stem cell transplantation (SCT) before the age of 2 years halts disease progression. Graft failure limits the success of SCT. We analyzed data on HS patients transplanted in Europe to identify the risk factors for graft failure. We compared outcomes in 146 HS patients transplanted with various conditioning regimens and grafts. Patients were transplanted between 1994 and 2004 and registered to the European Blood and Marrow Transplantation database. Risk factor analysis was performed using logistic regression. ‘Survival’ and ‘alive and engrafted’-rate after first SCT was 85 and 56%, respectively. In multivariable analysis, T-cell depletion (odds ratio (OR) 0.18; 95% confidence interval (CI) 0.04–0.71; P=0.02) and reduced-intensity conditioning (OR 0.08; 95% CI 0.02–0.39; P=0.002) were the risk factors for graft failure. Busulfan targeting protected against graft failure (OR 5.76; 95% CI 1.20–27.54; P=0.028). No difference was noted between cell sources used (bone marrow, peripheral blood stem cells or cord blood (CB)); however, significantly more patients who received CB transplants had full-donor chimerism (OR 9.31; 95% CI 1.06–82.03; P=0.044). These outcomes may impact the safety/efficacy of SCT for ‘inborn-errors of metabolism’ at large. CB increased the likelihood of sustained engraftment associated with normal enzyme levels and could therefore be considered as a preferential cell source in SCT for ‘inborn errors of metabolism’.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Overview of the mucopolysaccharidoses
Muenzer, J. (2011) · Rheumatology · doi:10.1093/rheumatology/ker394 · Cited by 486
Mucopolysaccharidosis I: Management and Treatment Guidelines
Muenzer, J., Wraith, J. E., Clarke, L. A., & and the International Consensus Panel on the Management and Treatment of Mucopolysaccharidosis, I. (2009) · Pediatrics · doi:10.1542/peds.2008-0416 · Cited by 460
Self-citationSanfilippo syndrome: A mini‐review
Valstar, M. J., Ruijter, G. J. G., van Diggelen, O. P., Poorthuis, B. J., & Wijburg, F. A. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0838-5 · Cited by 396
Aldenhoven, M., Wynn, R. F., Orchard, P. J., O’Meara, A., Veys, P., Fischer, A., Valayannopoulos, V., Neven, B., Rovelli, A., Prasad, V. K., et al. (2015) · Blood · doi:10.1182/blood-2014-11-608075 · Cited by 321
Self-citationPrasad, V. K., Mendizabal, A., Parikh, S. H., Szabolcs, P., Driscoll, T. A., Page, K., Lakshminarayanan, S., Allison, J., Wood, S., Semmel, D., et al. (2008) · Blood · doi:10.1182/blood-2008-03-140830 · Cited by 262
Metadata
- Authors
- Boelens, J. J., Wynn, R. F., O'Meara, A., Veys, P., Bertrand, Y., Souillet, G., Wraith, J. E., Fischer, A., Cavazzana-Calvo, M., Sykora, K. W., Sedlacek, P., Rovelli, A., Uiterwaal, C. S. P. M., & Wulffraat, N.
- Venue
- Bone Marrow Transplantation
- Published
- 2007-05-28
- Volume
- 40
- Issue
- 3
- Pages
- 225-233
- ISSN
- 0268-3369 (ISSN-L)
- 1476-5365
- OpenAlex
- W2038713290
- Cited by
- 212
- References
- 0
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. https://app.cochat.ai/papers/10.1038/sj.bmt.1705718
- The paper
- Boelens, J. J., Wynn, R. F., O'Meara, A., Veys, P., Bertrand, Y., Souillet, G., Wraith, J. E., Fischer, A., Cavazzana-Calvo, M., Sykora, K. W., Sedlacek, P., Rovelli, A., Uiterwaal, C. S. P. M., & Wulffraat, N. (2007). Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplantation. https://doi.org/10.1038/sj.bmt.1705718
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.